Filing Details

Accession Number:
0001209191-15-067373
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-21 16:49:17
Reporting Period:
2015-08-19
Filing Date:
2015-08-21
Accepted Time:
2015-08-21 16:49:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557421 Ignyta Inc. RXDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283290 E Jonathan Lim C/O Ignyta, Inc.
11111 Flintkote Ave.
San Diego CA 92121
President, Ceo & Director Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-19 6,500 $12.95 3,323,168 No 4 P Indirect By City Hill Venture Partners I, LLC
Common Stock Acquisiton 2015-08-19 240 $13.05 3,323,408 No 4 P Indirect By City Hill Venture Partners I, LLC
Common Stock Acquisiton 2015-08-20 1,700 $12.69 3,325,108 No 4 P Indirect By City Hill Venture Partners I, LLC
Common Stock Acquisiton 2015-08-20 40 $12.77 3,325,148 No 4 P Indirect By City Hill Venture Partners I, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By City Hill Venture Partners I, LLC
No 4 P Indirect By City Hill Venture Partners I, LLC
No 4 P Indirect By City Hill Venture Partners I, LLC
No 4 P Indirect By City Hill Venture Partners I, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,000 Direct
Footnotes
  1. Reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $12.73 to $13.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The Reporting Person is the Manager of City Hill Ventures, LLC, which is the Manager of City Hill Ventures Partners I, LLC, and as such the Reporting Person and City Hill Ventures, LLC have the power to vote or dispose of the securities held of record by the Reporting Person and may be deemed to beneficially own those securities. The Reporting Person disclaims beneficial ownership of the securities held of record by City Hill Venture Partners I, LLC except to the extent of his pecuniary interest therein.
  3. Reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  4. Reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $12.50 to $13.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.